Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer

British Journal of Cancer

Volumn 83, Issue 5, 2000, Pages 573-576

  Beretta, G D ^a   Michetti, G ^a   Belometti, M O ^a   Gritti, G ^a   Quadri, A ^a   Poletti, P ^a   Labianca, R ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Elderly patients; Gemcitabine; NSCLC; Unfit patients; Vinorelbine

Indexed keywords

AMINOTRANSFERASE; CISPLATIN; GEMCITABINE; METOCLOPRAMIDE; NAVELBINE; ONDANSETRON;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME DEFECT; FEMALE; GASTROINTESTINAL TOXICITY; GRANULOCYTOPENIA; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION; VOMITING;

EID: 0033894412     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1304     Document Type: Article

References (26)

1. Bonomi P (1999) Review of paclitaxel/carboplatin in advanced non-small cell lung cancer. Sernin Oncol 26(suppl 2): 55-59
2. Bunn PA Jr (1993) Future directions in the management of non-small cell lung cancer. Lung Cancer 9(suppl 2): 91-127
3. Cigolari S, Gridelli C, Frontini L, Gulisano M, Robbiati SF, Farris A, Clerici M, Castiglione F, Piazza E, Ianniello GP and Perrone F (1998) Gemcitabine + vinorelbine (GEMVIN) in the treatment of advanced non-small cell lung cancer (NSCLC). Sequential phase I and phase II trials. Proc ESMO 9: 87 (abs 419P)
4. De Candis D, Bidoli P, Cresta S, Artale S, Masi G and Bajetta E (1998) Phase II study of gemcitabine (GEM) plus navelbine (NVB) in previously untreated stage III or IV non-small cell lung cancer (NSCLC). Proc ESMO 9: (abs 460) 95
5. Esteban F, Llano JLG, Vieitez Jin, Fra J, Puertas J, Estrada E, Palacio I, Mumiz I, Buesa JM and Lacave AJ (1998) Phase I/II study of gemcitabine plus vinorelbine in non small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 17: (abs 1855) 482a
6. Feliu J, Lopez-Gomez L, Madronal C, Jalon I, Garcia-Giron J, Castro J, Martinez B, Iglesias J, Zamora P and Gonzales-Baron M (1998) Phase II study of gemcitabine-vinorelbine (G-V) in patients with advanced non small cell lung cancer (NSCLC) over 70 year-old or with contraindication to receive cisplatin. Proc ESMO 9: (abs 411P) 85
7. Fossella FV, Lee JS, Shin DM, Calayag M, Huber M, Perez-Soler R, Murphy WK, Lippman S, Benner S and Glisson B (1995) Phase II study of docetaxel for advanced or metastatic platinum-refractary non-small cell lung cancer. J Clin Oncol 13: 645-651
8. Frasci G, Panza N, Comella P, Nicolella GP, Natale M, Pacilio C, Gravina A, Caputi V, Botti G and Comella G (1997) Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a Phase I study. Ann Oncol 8: 1045-1048
9. Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyania T, Ariyoshi Y, Negoro S and Masuda N (1992) A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small cell lung cancer. J Clin Oncol 10: 16-20
10. Gatzemeier U, Heckmayr M, Neuhauss R, Schluter I, Pawel JV, Wagner H and Dreps A (1995) Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer. Lung Cancer 12:(suppl 2) 101-106
11. Goss GD, Logan DM, Newmann TE and Evans WK (1997) Use of vinorelbine in non-small cell lung cancer. Provincial Lung Disease Site Group. Cancer Prev Control 1: 28-38
12. Isokangas OP, Knuuttila A, Halme M, Mantyla M, Lindstrom I, Nakkanen V, Viren M, Joensuu H and Mattson K (1999) Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer. Ann Oncol 10: 1059-1063
13. Klastersky J, Sculler JP, Lacroix H, Dabouis G, Bureau G, Libert P, Richez M, Ravez P, Vandermoten G and Thiriaux J (1990) A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer protocol 07861. J Clin Oncol 8: 1556-1562
14. Langer CJ, Leigthon JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S and Ozols RF (1995) Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 13: 1860-1870
15. Le Chevalier T (1996) Chemotherapy of non-small-lung cancers. Presse Med 25: 1699-1703
16. Lilenbaum RC, Green MR (1993) Novel chemotherapeutic agents in the treatment of non-small cell lung cancer. J Clin Oncol 11: 1391-1402
17. Lilenbaum RC, Schwartz MA, Cano R, Krill E, Lutzky J, Baulstein A, Seigel L, Viales M, Dominguez CJ and Davila E (1998) Gemcitabine (GEM) and navelbine (NVB) in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 17:494a (abs 1901)
18. Lorusso V, Carpagnano F, Frasci G, Panza N, Di Rienzo G, Cisternino ML, Napoli G, Orlando S, Cinieri S, Brunetti C, Palazzo S and De Lena M (2000) Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small cell lung cancer. J Clin Oncol 18: 405-111
19. Noble S and Goa KL (1997) Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs 54: 447-472
20. Non-Small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311: 899-909
21. Non Small Cell Lung Cancer Expert Panel (1997) Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. J Clin Oncol 15: 2996-3018
22. Parker SL, Tong T, Bolden S and Wingo PA (1996) Cancer statistics. CA Cancer J Clin 65: 5-27
23. Simon R (1989) Optimal two-stage design for phase II clinical trials. Control Clin Trials 10: 1-10
24. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA, Kaasa S, Pater JL, Quoix E and Rapp E (1993) Polychemotherapy in advanced non-small cell lung cancer: A meta-analysis. Lancet 342: 19-21
25. The Elderly Lung Cancer Vinorelbine Italian Study Group (ELCVIS) (1999) Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst 91: 66-72
26. Zanetti R, Buiatti E, Federico M and Micheli A (1998) Fatti e cifre dei tumori in Italia. II Pensiero Scientifico: Roma